CRISPR-based Gene Editing Market, By Product & Service (Products and Services), By Application, By End Use, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV5275
|
Published Date
May 2026
|
Pages
387
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
CRISPR-based Gene Editing Market size was valued at US$ 4,605.2 Million in 2025, expanding at a CAGR of 15.1% from 2026 to 2033.
CRISPR-based gene editing refers to a set of advanced biotechnology tools that enable precise modification of DNA sequences within living organisms. It allows researchers to add, remove, or alter genetic material at specific genomic locations, significantly improving the accuracy and efficiency of genetic engineering. The CRISPR-based gene editing market represents a major advancement in molecular biology and biotechnology, enabling highly targeted and efficient genome editing applications. For instance, in 2025, research published by the National Institutes of Health highlights that modern molecular biology has advanced to single-cell resolution analysis, allowing scientists to study gene expression variability across thousands to millions of individual cells in a single experiment. This represents a major improvement over earlier bulk-level techniques, which averaged signals across entire tissues and limited the precision of genetic insights. Such advancements are expected to accelerate innovation and support broader adoption of CRISPR-based technologies in therapeutic applications.
CRISPR-based Gene Editing Market- Market Dynamics
Increasing Prevalence of Genetic Disorders Driving Market Growth
The rising prevalence of genetic disorders is driving increased research into rare and previously undiagnosed neurodevelopmental conditions, supported by advances in genome sequencing and clinical genomics. Recent discoveries, including newly identified mutations in genes such as RPS6KC1, are expanding the understanding of complex neurological and developmental diseases. These developments are strengthening early diagnostic capabilities and accelerating the progress of targeted therapies for rare genetic disorders.
The growing burden of genetic disorders globally is also increasing demand for CRISPR-based gene editing, as it enables precise correction of disease-causing mutations and supports the development of next-generation, targeted genetic therapies. For instance, in 2026, insights from the Centers for Disease Control and Prevention highlight that genetic disorders arise from changes in DNA, ranging from single-gene mutations to chromosomal abnormalities and complex interactions between multiple genes and environmental factors. The CDC reports that rare and genetic conditions include disorders such as Down syndrome, which affects approximately 1 in 700 births, and cystic fibrosis, which impacts around 35,000 individuals in the United States. Therefore, the increasing prevalence of genetic disorders is accelerating the adoption of CRISPR technologies for precise, personalized, and potentially curative therapeutic applications.
CRISPR-based Gene Editing Market- Segmentation Analysis:
The Global CRISPR-based Gene Editing Market is segmented on the basis of Product & Service , Application, End Use, and Region.
From a product and service perspective, CRISPR kits and reagents hold a significant share in the CRISPR-based gene editing market due to their extensive use in genome editing workflows, strong research adoption, and critical role in enabling precise gene modification. These tools are essential for conducting gene editing experiments in both academic and commercial research settings, supporting advancements in biotechnology and molecular medicine. For instance, research by the Department of Pharmaceuticals, Government of India, highlights that the growing demand for diagnostic kits and reagents is significantly contributing to the expansion of India’s medical devices industry. The report notes that India’s dependence on imports for in-vitro diagnostic (IVD) reagents increased by approximately 65.4%, reaching around USD 872 million due to rising diagnostic testing demand. Additionally, medical device imports reached nearly USD 8.5 billion, growing by 36.8% in line with the expansion of healthcare screening and diagnostic infrastructure. Therefore, the increasing use of diagnostic and research applications is driving global demand for CRISPR kits and reagents.
In terms of application, the biomedical segment represents a key area in the CRISPR-based gene editing market, driven by its expanding use in therapeutic development, genetic disorder treatment, oncology research, disease diagnostics, and the growing adoption of both ex vivo and in vivo gene editing technologies. For instance, in 2025, research by the Organisation for Economic Co-operation and Development highlights that Japan is experiencing increasing adoption of biomedical and advanced healthcare technologies. The country spends approximately 10.6% of its GDP on healthcare, with per capita healthcare expenditure reaching nearly USD 5,790 and universal health coverage for its entire population. Japan also has about 184 CT, MRI, and PET scanners per million people and approximately 203 pharmacists per 100,000 population, reflecting strong integration of advanced medical technologies. As a result, the expansion of healthcare infrastructure is accelerating the adoption of CRISPR-based technologies in biomedical applications.
CRISPR-based Gene Editing Market- Geographical Insights
North America holds a strong position in the CRISPR-based gene editing market, driven by the presence of leading biotechnology and pharmaceutical companies along with sustained investments in research and development. In April 2025, Danaher Corporation advanced its CRISPR capabilities by strengthening its R&D ecosystem through its subsidiaries Integrated DNA Technologies (IDT) and Aldevron. The focus is on producing high-quality DNA, RNA, and CRISPR-related tools to accelerate the development of next-generation gene editing therapies and improve the scalability of personalized treatment solutions. This continued innovation reinforces North America’s leadership in CRISPR research and therapeutic development.
Moreover, the Asia-Pacific region is expected to grow rapidly in the CRISPR-based gene editing market, supported by the expansion of biotechnology and pharmaceutical industries. Countries such as China, Japan, South Korea, and India are significantly increasing investments in genomic research, clinical trials, and CRISPR-based product development, supported by favorable government initiatives and policy reforms. In May 2025, according to the Press Information Bureau, India’s Union Minister for Agriculture and Farmers Welfare launched the country’s first genome-edited rice varieties, DRR Rice 100 (Kamla) and Pusa DST Rice 1, developed by the Indian Council of Agricultural Research (ICAR) using CRISPR-based genome editing. These varieties offer higher yields, improved climate resilience, and better water-use efficiency. With this achievement, India became the first country to develop genome-edited rice varieties, highlighting the region’s growing leadership in CRISPR innovation driven by strong policy support.
China also plays a pivotal role in the CRISPR-based gene editing market, having been among the earliest countries to conduct human clinical trials using CRISPR-Cas9 for genetic disorders. According to the National Institutes of Health, China’s modern clinical trial system has evolved from limited early-stage studies to a large-scale, multicenter randomized clinical research framework. Today, hundreds of multicenter randomized controlled trials (RCTs) are conducted across key therapeutic areas such as oncology, cardiovascular diseases, infectious diseases, and traditional medicine. Modern clinical trials now involve several hundred to over 3,000 participants per Phase II and Phase III study, compared to fewer than 100 participants in earlier periods. Therefore, the expansion of China’s clinical research ecosystem is significantly accelerating advancements in CRISPR gene editing technologies.
CRISPR-based Gene Editing Market- Competitive Landscape:
The CRISPR-based gene editing market is highly competitive and moderately consolidated, with several global and specialized biotechnology companies driving innovation, commercialization, and clinical adoption. Key players such as CRISPR Therapeutics, Agilent Technologies, Thermo Fisher Scientific, GeneCopoeia, and Synthego are strengthening their market positions through advanced genome editing platforms, expanded research applications, and continuous innovation in gene modification technologies. In May 2025, Danaher Corporation utilized its integrated business system to deliver the world’s first mRNA-based personalized CRISPR therapy in under six months, accelerating treatment for a child with neonatal-onset CPS1 deficiency. This milestone highlights how ongoing innovation is accelerating the development and clinical adoption of CRISPR-based therapies worldwide.
Recent Developments
- In May 2025, Bio-Techne entered into a collaboration with Kytopen to integrate Flowfect® continuous flow technology with advanced gene delivery systems. This partnership enables scalable, non-viral CRISPR-mediated T-cell engineering and improves efficiency in cell therapy manufacturing workflows.
- In April 2025, Synthego expanded its CRISPR licensing ecosystem through a strategic agreement with Vita Therapeutics to integrate high-fidelity hfCas12Max nuclease technology into next-generation cell therapy programs, enhancing precision and reducing off-target gene editing risks.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CRISPR-BASED GENE EDITING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Revvity, Inc.
- Danaher Corporation
- GenScript Biotech Corporation
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Tocris Bioscience
- OriGene Technologies, Inc.
- Bio-Rad Laboratories
- Bio-Techne Corporation
- New England Biolabs, Inc.
- CRISPR Therapeutics AG
- Agilent Technologies, Inc.
- GeneCopoeia, Inc.
- Synthego Corporation
- System Biosciences LLC
- ToolGen, Inc.
- Rockland Immunochemicals, Inc.
- Horizon Discovery Group
- Abcam, Inc.
- Applied StemCell, Inc.
- Cellecta, Inc.
- Others
GLOBAL CRISPR-BASED GENE EDITING MARKET, BY PRODUCT & SERVICE - MARKET ANALYSIS, 2020 - 2033
- Products
- CRISPR Libraries
- CRISPR Kits & Reagents
- Others
- Services
- Others
GLOBAL CRISPR-BASED GENE EDITING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- By Delivery Method
- Ex Vivo
- In Vivo
- Disease Diagnostics
- Agricultural applications
- Farm Animals Engineering
- Plant Engineering
- Others
- Biomedical
- Therapeutic Development
- By Indication
- Ophthalmology
- Oncology
- Genetic Disorders
- Others
GLOBAL CRISPR-BASED GENE EDITING MARKET, BY END USE- MARKET ANALYSIS, 2020 - 2033
- Contract Research Organizations
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Others
GLOBAL CRISPR-BASED GENE EDITING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. CRISPR-based Gene Editing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. CRISPR-based Gene Editing Market Snippet by Product & Service
2.1.2. CRISPR-based Gene Editing Market Snippet by Application
2.1.3. CRISPR-based Gene Editing Market Snippet by End Use
2.1.4. CRISPR-based Gene Editing Market Snippet by Country
2.1.5. CRISPR-based Gene Editing Market Snippet by Region
2.2. Competitive Insights
3. CRISPR-based Gene Editing Key Market Trends
3.1. CRISPR-based Gene Editing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. CRISPR-based Gene Editing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. CRISPR-based Gene Editing Market Opportunities
3.4. CRISPR-based Gene Editing Market Future Trends
4. CRISPR-based Gene Editing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. CRISPR-based Gene Editing Market : Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. CRISPR-based Gene Editing Market Landscape
6.1. CRISPR-based Gene Editing Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. CRISPR-based Gene Editing Market – By Product & Service
7.1. Overview
7.1.1. Segment Share Analysis, By Product & Service , 2025 & 2033 (%)
7.1.2. Products
7.1.2.1. CRISPR Libraries
7.1.2.2. CRISPR Kits & Reagents
7.1.2.3. Others
7.1.3. Services
7.1.4. Others
8. CRISPR-based Gene Editing Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
8.1.2. By Delivery Method
8.1.2.1. Ex Vivo
8.1.2.2. In Vivo
8.1.3. Disease Diagnostics
8.1.4. Agricultural applications
8.1.4.1. Farm Animals Engineering
8.1.4.2. Plant Engineering
8.1.4.3. Others
8.1.5. Biomedical
8.1.5.1. Therapeutic Development
8.1.5.1.1. By Indication
8.1.5.1.2. Ophthalmology
8.1.5.1.3. Oncology
8.1.5.1.4. Genetic Disorders
8.1.5.1.5. Others
8.1.6. XX
9. CRISPR-based Gene Editing Market – By End Use
9.1. Overview
9.1.1. Segment Share Analysis, By End Use, 2025 & 2033 (%)
9.1.2. Contract Research Organizations
9.1.3. Academic & Research Institutes
9.1.4. Pharmaceutical & Biotechnology Companies
9.1.5. Others
10. CRISPR-based Gene Editing Market – By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
10.2. North America
10.2.1. Overview
10.2.2. CRISPR-based Gene Editing Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.2.4. North America Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.2.6. North America Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. CRISPR-based Gene Editing Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.9.5. France Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.3.16. Denmark
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.16.3. Denmark Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.16.5. Denmark Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.3.17. Rest of Europe
10.3.17.1. Overview
10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.17.3. Rest of the Europe Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.17.5. Rest of the Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. CRISPR-based Gene Editing Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.6. APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.7.5. China Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.8.5. India Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.4.15. Taiwan
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.15.3. Taiwan Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.15.5. Taiwan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.4.16. Vietnam
10.4.16.1. Overview
10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.16.3. Vietnam Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.16.5. Vietnam Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.4.17. Rest of APAC
10.4.17.1. Overview
10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.17.3. Rest of APAC Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.17.5. Rest of APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. CRISPR-based Gene Editing Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. CRISPR-based Gene Editing Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.6. MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.6.13. Iran
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.13.3. Iran Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.13.5. Iran Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.6.14. Qatar
10.6.14.1. Overview
10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.14.3. Qatar Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.14.5. Qatar Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
10.6.15. Rest of MEA
10.6.15.1. Overview
10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.15.3. Rest of MEA Market Size and Forecast, By Product & Service , 2020 - 2033 (US$ Million)
10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.15.5. Rest of MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11. Key Vendor Analysis- CRISPR-based Gene Editing Industry
11.1. Competitive Benchmarking
11.1.1. Competitive Dashboard
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Revvity, Inc.
11.2.2. Danaher Corporation
11.2.3. GenScript Biotech Corporation
11.2.4. Merck KGaA
11.2.5. Thermo Fisher Scientific, Inc.
11.2.6. Tocris Bioscience
11.2.7. OriGene Technologies, Inc.
11.2.8. Bio-Rad Laboratories
11.2.9. Bio-Techne Corporation
11.2.10. New England Biolabs, Inc.
11.2.11. CRISPR Therapeutics AG
11.2.12. Agilent Technologies, Inc.
11.2.13. GeneCopoeia, Inc.
11.2.14. Synthego Corporation
11.2.15. System Biosciences LLC
11.2.16. ToolGen, Inc.
11.2.17. Rockland Immunochemicals, Inc.
11.2.18. Horizon Discovery Group
11.2.19. Abcam, Inc.
11.2.20. Applied StemCell, Inc.
11.2.21. Cellecta, Inc.
11.2.22. Others
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CRISPR-BASED GENE EDITING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Revvity, Inc.
- Danaher Corporation
- GenScript Biotech Corporation
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Tocris Bioscience
- OriGene Technologies, Inc.
- Bio-Rad Laboratories
- Bio-Techne Corporation
- New England Biolabs, Inc.
- CRISPR Therapeutics AG
- Agilent Technologies, Inc.
- GeneCopoeia, Inc.
- Synthego Corporation
- System Biosciences LLC
- ToolGen, Inc.
- Rockland Immunochemicals, Inc.
- Horizon Discovery Group
- Abcam, Inc.
- Applied StemCell, Inc.
- Cellecta, Inc.
- Others
GLOBAL CRISPR-BASED GENE EDITING MARKET, BY PRODUCT & SERVICE - MARKET ANALYSIS, 2020 - 2033
- Products
- CRISPR Libraries
- CRISPR Kits & Reagents
- Others
- Services
- Others
GLOBAL CRISPR-BASED GENE EDITING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- By Delivery Method
- Ex Vivo
- In Vivo
- Disease Diagnostics
- Agricultural applications
- Farm Animals Engineering
- Plant Engineering
- Others
- Biomedical
- Therapeutic Development
- By Indication
- Ophthalmology
- Oncology
- Genetic Disorders
- Others
GLOBAL CRISPR-BASED GENE EDITING MARKET, BY END USE- MARKET ANALYSIS, 2020 - 2033
- Contract Research Organizations
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Others
GLOBAL CRISPR-BASED GENE EDITING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
